{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:07:38Z","timestamp":1784786858944,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese Special Funds for Scientific Research on Public Causes","award":["201502010"],"award-info":[{"award-number":["201502010"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Plan","doi-asserted-by":"publisher","award":["201 8YFC1314003"],"award-info":[{"award-number":["201 8YFC1314003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cmi.2019.12.003","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T12:25:02Z","timestamp":1576499102000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"26","author":[{"given":"K.X.","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u00f6hlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.12.003_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.ajkd.2014.12.014","article-title":"Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons","volume":"65","author":"Pisoni","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2231-0770.90913","article-title":"Tissue plasminogen activator versus heparin for locking dialysis catheters: a systematic review","volume":"1","author":"Firwana","year":"2011","journal-title":"Avicenna J Med"},{"issue":"11","key":"10.1016\/j.cmi.2019.12.003_bib4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.2215\/CJN.08961209","article-title":"Change in vascular access and hospitalization risk in long-term hemodialysis patients","volume":"5","author":"Lacson","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/ndt\/gfl170","article-title":"Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces","volume":"21","author":"Shanks","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2019.12.003_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/039139880102400407","article-title":"A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters","volume":"24","author":"Hendrickx","year":"2001","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cmi.2019.12.003_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2215\/CJN.01760407","article-title":"Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS)","volume":"3","author":"MacRae","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1053\/j.ajkd.2015.04.047","article-title":"Cathasept line lock and microbial colonization of tunneled hemodialysis catheters: a multicenter randomized controlled trial","volume":"66","author":"Kanaa","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2007.10.038","article-title":"A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection","volume":"51","author":"Jaffer","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib10","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1093\/ndt\/gft406","article-title":"Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: systematic review and meta-analysis of randomized, controlled trials","volume":"28","author":"Wang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2019.12.003_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.ajkd.2013.08.016","article-title":"Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Zhao","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib12","first-page":"11985","article-title":"Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.cmi.2019.12.003_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009631.pub2","article-title":"Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease","author":"Wang","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2019.12.003_bib14","article-title":"Interventions for treating central venous haemodialysis catheter malfunction","volume":"10","author":"Kennard","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2019.12.003_bib15","article-title":"Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis","volume":"4","author":"Arechabala","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2019.12.003_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11255-016-1490-x","article-title":"Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis","volume":"49","author":"Zhang","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib17","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.12.003_bib19","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/j.cmi.2019.12.003_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.cmi.2019.12.003_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinepi.2014.08.012","article-title":"Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data","volume":"68","author":"Rhodes","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cmi.2019.12.003_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cmi.2019.12.003_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1525-1594.1998.06268.x","article-title":"Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study","volume":"22","author":"Buturovi\u0107","year":"1998","journal-title":"Artif Organs"},{"key":"10.1016\/j.cmi.2019.12.003_bib24","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1097\/01.ASN.0000022890.29656.22","article-title":"Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study","volume":"13","author":"Dogra","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/112972980200300305","article-title":"Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia","volume":"3","author":"Pervez","year":"2002","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.cmi.2019.12.003_bib26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/ndt\/gfh014","article-title":"Prevention of dialysis catheter-related sepsis with a citrate\u2013taurolidine-containing lock solution","volume":"19","author":"Betjes","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2019.12.003_bib27","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1681\/ASN.2004100870","article-title":"Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients","volume":"16","author":"Weijmer","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2006.06.012","article-title":"Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia","volume":"48","author":"Nori","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/j.ajkd.2009.01.259","article-title":"Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial","volume":"53","author":"Power","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/j.ajkd.2009.11.025","article-title":"A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis","volume":"55","author":"Solomon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000324685","article-title":"Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial","volume":"33","author":"Filiopoulos","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/CCM.0b013e318206b5a2","article-title":"A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial","volume":"39","author":"Maki","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.12.003_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.ajkd.2011.08.031","article-title":"A randomized trial comparing gentamicin\/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients","volume":"59","author":"Moran","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/502578","article-title":"A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access","volume":"26","author":"Bleyer","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.cmi.2019.12.003_bib35","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1681\/ASN.2010121306","article-title":"Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis","volume":"22","author":"Campos","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000081811","article-title":"Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis","volume":"22","author":"Kaneko","year":"2004","journal-title":"Blood Purif"},{"key":"10.1016\/j.cmi.2019.12.003_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000328743","article-title":"Low-dose heparin retention in temporary hemodialysis double-lumen catheter does not increase catheter occlusion and might reduce risk of bleeding","volume":"32","author":"Hu","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.cmi.2019.12.003_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5414\/CN106460","article-title":"The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients","volume":"75","author":"Thomson","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/0886022X.2011.646884","article-title":"Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial","volume":"34","author":"Oguzhan","year":"2012","journal-title":"Ren Fail"},{"key":"10.1016\/j.cmi.2019.12.003_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMoa1011376","article-title":"Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator","volume":"364","author":"Hemmelgarn","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.12.003_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MAT.0b013e3181c84e61","article-title":"Comparison between standard heparin and tinzaparin for haemodialysis catheter lock","volume":"56","author":"Malo","year":"2010","journal-title":"ASAIO J"},{"key":"10.1016\/j.cmi.2019.12.003_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2012.10.014","article-title":"Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled Trial","volume":"61","author":"Bonkain","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s15010-016-0929-4","article-title":"Comparative effectiveness of 30% trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial)","volume":"45","author":"Barcellos","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2019.12.003_bib44","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/hdi.12492","article-title":"The CLOCK trial, a double-blinded randomized controlled trial: trisodium citrate 30% and minocycline 3 mg\/mL plus EDTA 30 mg\/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis","volume":"21","author":"Luiz","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11255-012-0151-y","article-title":"Low concentration of heparin used for permanent catheters canal locking is effective and diminishes the risk of bleeding","volume":"45","author":"Hryszko","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"121","key":"10.1016\/j.cmi.2019.12.003_bib46","article-title":"Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: a randomized controlled trial","volume":"3","author":"Beigi","year":"2014","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.cmi.2019.12.003_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/hdi.12401","article-title":"Low dose heparin lock (1000 U\/mL) maintains tunnelled hemodialysis catheter patency when compared with high dose heparin (5000 U\/mL): a randomised controlled trial","volume":"20","author":"Chu","year":"2016","journal-title":"Hemodial Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5301\/jva.5000486","article-title":"An ethanol\/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study","volume":"17","author":"Vercaigne","year":"2016","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.cmi.2019.12.003_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/0886022X.2013.830207","article-title":"Concentrated sodium chloride catheter lock solution\u2013a new effective alternative method for hemodialysis patients with high bleeding risk","volume":"36","author":"Chen","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.cmi.2019.12.003_bib50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ndt\/gfx187","article-title":"Safety and efficacy of taurolidine\/urokinase versus taurolidine\/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study","volume":"33","author":"Al-Ali","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2019.12.003_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2369-13-146","article-title":"A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients\u2013the HEALTHY-CATH trial","volume":"13","author":"Broom","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2017.06.026","article-title":"Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters","volume":"93","author":"Winnicki","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/hdi.12524","article-title":"Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients: a prospective randomized study","volume":"21","author":"Sofroniadou","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib54","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1523-1755.2004.00806.x","article-title":"Locking of tunneled hemodialysis catheters with gentamicin and heparin","volume":"66","author":"McIntyre","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib55","first-page":"755","article-title":"The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study","volume":"18","author":"Saxena","year":"2005","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1797.2006.00563.x","article-title":"Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial","volume":"11","author":"Saxena","year":"2006","journal-title":"Nephrology"},{"key":"10.1016\/j.cmi.2019.12.003_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.ki.5000012","article-title":"Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial","volume":"69","author":"Kim","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib58","first-page":"239","article-title":"Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin","volume":"18","author":"Al-Hwiesh","year":"2007","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.cmi.2019.12.003_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000197560","article-title":"Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method","volume":"27","author":"Zhang","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.cmi.2019.12.003_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1525-139X.2011.00965.x","article-title":"Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study","volume":"25","author":"Sofroniadou","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.cmi.2019.12.003_bib61","first-page":"328","article-title":"Cloxacillin as an antibiotic lock solution for prevention of catheter-associated infection","volume":"5","author":"Davanipur","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib62","first-page":"303","article-title":"Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime","volume":"16","author":"Mortazavi","year":"2011","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.cmi.2019.12.003_bib63","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4103\/1319-2442.98154","article-title":"Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers","volume":"23","author":"Saxena","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.cmi.2019.12.003_bib64","first-page":"98","article-title":"Effects of heparin lock-antibiotics to prevent infections in patients undergoing hemodialysis: a clinical trial","volume":"22","author":"Shirzad","year":"2013","journal-title":"J\u00a0Mazandaran Univ Med Sci"},{"key":"10.1016\/j.cmi.2019.12.003_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/fmb.14.116","article-title":"Prevention of hemodialysis catheter-related blood stream infections using a cotrimoxazole-lock technique","volume":"10","author":"Moghaddas","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cmi.2019.12.003_bib66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00134-011-2422-y","article-title":"Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial","volume":"38","author":"Hermite","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2019.12.003_bib67","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5414\/CN109162","article-title":"A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients","volume":"90","author":"Abdel","year":"2018","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib68","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1164\/rccm.201408-1431OC","article-title":"Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial","volume":"191","author":"Souweine","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.cmi.2019.12.003_bib69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cid\/ciy840","article-title":"Locking hemodialysis catheters with trimethoprim-ethanol-Ca-EDTA to prevent bloodstream infections. A randomized, evaluator blinded clinical trial","volume":"69","author":"Rijnders","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ndt\/gfx277","article-title":"Mortality risk in patients on hemodiafiltration versus hemodialysis: a \u201creal-world\u201d comparison from the DOPPS","volume":"33","author":"Locatelli","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2019.12.003_bib71","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2215\/CJN.11411116","article-title":"National healthcare safety network (NHSN) dialysis event surveillance report for 2014","volume":"12","author":"Nguyen","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.cmi.2019.12.003_bib72","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.01270210","article-title":"Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis","volume":"5","author":"Landry","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2019.12.003_bib73","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00365540701756953","article-title":"Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial","volume":"40","author":"Broom","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2019.12.003_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhin.2006.01.009","article-title":"Ethanol disinfection of plastic-adherent micro-organisms","volume":"63","author":"Chambers","year":"2006","journal-title":"J\u00a0Hosp Infect"},{"issue":"7","key":"10.1016\/j.cmi.2019.12.003_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00091-17","article-title":"A novel non-antibiotic nitroglycerin based catheter lock solution for the prevention of intraluminal central venous catheter infections in cancer patients","volume":"61","author":"Chaftari","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.12.003_bib76","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jpedsurg.2011.02.036","article-title":"Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience","volume":"46","author":"Wales","year":"2011","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.cmi.2019.12.003_bib77","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/jac\/dku182","article-title":"Adverse effects associated with ethanol catheter lock solutions: a systematic review","volume":"69","author":"Mermel","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2019.12.003_bib78","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jpedsurg.2010.05.014","article-title":"Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections","volume":"45","author":"Kayton","year":"2010","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.cmi.2019.12.003_bib79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1594.2011.01290.x","article-title":"Thrombosis of tunneled-cuffed hemodialysis catheters: treatment with high-dose urokinase lock therapy","volume":"36","author":"Donati","year":"2012","journal-title":"Artif Organs"},{"key":"10.1016\/j.cmi.2019.12.003_bib80","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5301\/jva.5000576","article-title":"Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus","volume":"17","author":"Pittiruti","year":"2016","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.cmi.2019.12.003_bib81","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/ndt\/gfp651","article-title":"Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial","volume":"25","author":"Bosma","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2019.12.003_bib82","series-title":"FDA issues warning on tricitrasol dialysis catheter anticoagulant. FDA Talk Paper T00-16","year":"2000"},{"key":"10.1016\/j.cmi.2019.12.003_bib83","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1046\/j.1523-1755.2000.00439.x","article-title":"Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study","volume":"58","author":"Oliver","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.cmi.2019.12.003_bib84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00003246-199205000-00020","article-title":"Biofilms on indwelling vascular catheters","volume":"20","author":"Passerini","year":"1992","journal-title":"Crit Care Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930655X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930655X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:32Z","timestamp":1761117872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1930655X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1198743X1930655X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.12.003","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}